Varian Medical Systems

Global Radiotherapy Market Report 2021-2026: Siemens Healthineers Will Take the Global Fight Against Cancer to a New Level - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021
General Health, Infectious Diseases, Health, Radiology, Oncology, Ethos, Varian Medical Systems, Deep learning, COVID-19, Artificial intelligence, Internal, Acquisition, Patient, Growth, Oncology, Incidence, AI, Siemens Healthineers, Cancer, Medtech, Radiation, USD, Prevalence, Medical device, Medical imaging

The global radiotherapy market is forecasted to reach USD 7987.01 Million in the year 2020.

Key Points: 
  • The global radiotherapy market is forecasted to reach USD 7987.01 Million in the year 2020.
  • Further, expanding healthcare infrastructure accompanied with rising R&D activities is expected to propel the radiotherapy market during the forecast period.
  • Artificial Intelligence (AI) is a leading trend in the radiotherapy market and is gaining significant popularity in the market.
  • With a highly integrated approach, Siemens Healthineers will take the global fight against cancer to a new level.

Global Oncology Information Systems Market Analysis Report 2021-2028: Focus on Software, Patient Information Systems, Treatment Planning System, Professional Services - ResearchAndMarkets.com

Retrieved on: 
Friday, August 13, 2021
Health, Data Management, Technology, Software, Oncology, OIS, Industry, Medical examiner, Co-production (public services), USS Prowess (AM-280), Oncology, Cerner, Disease, Philips, COVID-19, Elekta, Varian Medical Systems, Information, Mortality, Patient, HCG, Growth, Cancer, Brainlab, Radiation, Asia, Adoption, Immunotherapy, RaySearch Laboratories, Prevalence, Solution, Hospital, Pharmaceutical industry

The "Oncology Information Systems Market Share, Size, Trends, Industry Analysis Report, By Product and Services; By Application; By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Oncology Information Systems Market Share, Size, Trends, Industry Analysis Report, By Product and Services; By Application; By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Hence the treatment of cancer patients needs to be properly planned to reduce the mortality associated with the disease.
  • The increasing adoption of the information systems have led to the launch of new systems along with collaborations and acquisitions.
  • The service agreement between the two also includes Monaco treatment planning system and Elekta's MOSAIQ Oncology Information System.

Surround Medical Systems Announces FDA 510(k) Pre-market Clearance Of The PORTRAY™ Dental Imaging System

Retrieved on: 
Tuesday, August 10, 2021
Chapel, Department, University of North Carolina, Health, Company, Patient, 3D, Carbon, Technology, Department of Physics and Astronomy, University of Manchester, Time, Dentist, Radioactive decay, Mark (given name), Sale, Tooth decay, Tooth, 2D, Jaw, The Company, Chief Dental Officer (Canada), Fracture, Failure, Varian Medical Systems, University, FDA, Chapel Hill, Astronomy, Chief executive officer, Dentistry, Medical imaging

The PORTRAY system occupies a comparable footprint and uses the same procedural techniques as 2D machines currently installed in dental offices.

Key Points: 
  • The PORTRAY system occupies a comparable footprint and uses the same procedural techniques as 2D machines currently installed in dental offices.
  • The PORTRAY system deploys multiple X-ray beams to generate imaging "slices" that are reconstructed using the Company's proprietary softwareto create 3D tomosynthetic and 2D synthetic images that previously have not been commercially available.
  • Statements about the Company's future expectations and all other statements in this press release other than historical facts are forward-looking statements.
  • Since these statements involve risks and uncertainties and are subject to change at any time, the Company's actual results could differ materially from expected results.

Global Radiation Therapy in the Oncology Market (2021 to 2031) - Featuring Accuray, Elekta and General Electric Among Others - ResearchAndMarkets.com

Retrieved on: 
Monday, August 9, 2021
Radiology, Health, Oncology, Zap, CAGR, Diagnosis, Siemens, ICAD Inc., Hitachi, Cancer, Synchrocyclotron, HDR, Radiation, Industry, Proton, Growth, Patient, Varian Medical Systems, Synchrotron, Oncology, Safety, Photon, LINAC, General Electric Company, Cyclotron, Medical imaging, Pharmaceutical industry

Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation.

Key Points: 
  • Radiation therapy in the oncology market is a treatment method to treat any type of cancer/tumor with the help of radiation.
  • The term 'radiation therapy' mostly refers to external beam radiation therapy, but it also means internal beam radiation therapy too.
  • What are the major market drivers, challenges, and opportunities in the global radiation therapy in oncology market?
  • What was the market value of the leading segments of the global radiation therapy in oncology market in 2020?

TeamViewer and Siemens Healthineers Form Partnership to Enable New Remote Scanning Service WeScan for Diagnostic Imaging

Retrieved on: 
Thursday, August 5, 2021
MRS, Magnetic resonance imaging, MDAX, Solution, Frankfurt Stock Exchange, Maintenance, TMV, TeamViewer (company), International Organization for Standardization, Technology, EBIT, Automation, Internet, Customer, Siemens Healthineers, Partnership, Patient, SRS, Radiation, Varian Medical Systems, Euro, Conditional access, Artificial intelligence, CTS, Precision medicine, Information, Augmented reality, TeamViewer, Hospital, Health, Acquisition, Medical imaging, Risk management

TAMPA BAY, Fla., Aug. 5, 2021 /PRNewswire/ -- Siemens Healthineers has recently started offering its customers WeScan1. WeScan is a new service leveraging TeamViewer's connectivity technology, that helps healthcare providers to perform magnetic resonance imaging (MRI) examinations if they lack qualified radiology staff. With the WeScan service, customers may seek access to a pool of skilled remote imaging technologists who help operate the MRI scanner using syngo Virtual Cockpit, the remote scanning software of Siemens Healthineers. As Siemens Healthineers assists customers via WeScan from outside their own IT-network, real-time data transmission across the internet and high security standards are central requirements. Therefore, Siemens Healthineers has formed a new partnership with TeamViewer. TeamViewer's remote connectivity technology is now incorporated as part of the WeScan service offering because of its high security standards, powerful data transfer performance, and ease of operation.

Key Points: 
  • With the WeScan service, customers may seek access to a pool of skilled remote imaging technologists who help operate the MRI scanner using syngo Virtual Cockpit, the remote scanning software of Siemens Healthineers.
  • As Siemens Healthineers assists customers via WeScan from outside their own IT-network, real-time data transmission across the internet and high security standards are central requirements.
  • "TeamViewer has been an important partner for many years," says Wolfgang Heimsch, Head of Customer Services at Siemens Healthineers.
  • Lukas Baur, EVP Solution Sales at TeamViewer, comments: "With WeScan, Siemens Healthineers is offering a highly innovative service that provides genuine added value for its customers.

NovaSignal Appoints Mark Laret, President and CEO of UCSF Health, to its Board of Directors

Retrieved on: 
Thursday, August 5, 2021
Cloud computing, Chief executive officer, Robotics, Association, UC, Solution, Health, Ronald Reagan UCLA Medical Center, Diagnosis, Technology, Adoption, University, USC, Stroke, University of California, San Francisco, Council, American Hospital Association, Leadership, University of California, Irvine Medical Center, San Francisco Bay Area, Â, Food and Drug Administration, University of California, Los Angeles, Intelligence, New York Stock Exchange, Hospital, Association of American Medical Colleges, Varian Medical Systems, Nuance Communications, Safety, Academic health science centre, Nasdaq, Physician, GLOBE, Management, Medicine

It is a privilege to have Mark, a nationally recognized leader in healthcare, join NovaSignals board of directors.

Key Points: 
  • It is a privilege to have Mark, a nationally recognized leader in healthcare, join NovaSignals board of directors.
  • I look forward to working with the companys leadership and board of directors as they work to expand access to this innovative technology.
  • He serves on the board of directors for NASDAQ-listed Nuance Communications, and previously served on the board of NYSE-listed Varian Medical Systems.
  • Using cloud computing and data analytics, NovaSignal supports physicians in their clinical decision making of diseases identified through cerebral blood flow.

Artio Medical Welcomes Clinical, Regulatory, and Quality Executives

Retrieved on: 
Wednesday, July 14, 2021
Johnson & Johnson, Companies, Covidien, Medtronic, Tyco International, Cordis, LifeScan, Varian Medical Systems, Artio, Varian, Medical device, Economy of the United States

De Peralta comes to Artio from ExThera Medical Corporation where he served as the Vice President for Regulatory and Clinical Affairs.

Key Points: 
  • De Peralta comes to Artio from ExThera Medical Corporation where he served as the Vice President for Regulatory and Clinical Affairs.
  • Dale joins Artio with over 30 years of quality assurance experience for medical device companies.
  • Prior to Confluent Medical, Dale held quality leadership roles with BioInspire Technologies, Cordis, Covidien, LifeScan, Inc, and Varian Medical Systems.
  • "We are excited to welcome Erdie and Delane to the Artio team", said Dr. F. Nicholas Franano, President and CEO of Artio Medical.

Teknova Appoints Matt Lowell as CFO to Help the Company Achieve Long-term Strategic Goals

Retrieved on: 
Thursday, May 6, 2021
General Health, Health, Science, Fitness & Nutrition, Research, Siemens, Varian Medical Systems, Varian, Lowell, Massachusetts, Geography of Massachusetts, Economy of the United States, Companies

b'Teknova , a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, announced today that Matt Lowell has joined the company as Chief Financial Officer (CFO).

Key Points: 
  • b'Teknova , a leading manufacturer of cell culture media and supplements, protein purification buffers, and molecular biology reagents, announced today that Matt Lowell has joined the company as Chief Financial Officer (CFO).
  • Lowell brings with him nearly 20 years of financial and strategic leadership experience in the medical device industry.
  • From 2013 Lowell was Vice President of Finance at Varian Medical Systems, and then Vice President of Finance at Varex Imaging Corporation, having co-led its spinoff from Varian Medical Systems in 2017.
  • Matt shares our vision for the future of Teknova, and we are delighted to welcome him to the team.\xe2\x80\x9d\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210506005036/en/\n'

Varian and Icon Group Partner to Extend Commitment to Global Cancer Care

Retrieved on: 
Tuesday, April 27, 2021
Silicon Valley, Varian Medical Systems, Varian, Economy of the United States

This agreement further strengthens the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia.\nThe order is comprised of a variety of Varian linear accelerators and software including Halcyon, TrueBeam, and HyperArc.

Key Points: 
  • This agreement further strengthens the global partnership between Varian and Icon Group, together increasing access to care across regional and underserviced areas in Australia and Asia.\nThe order is comprised of a variety of Varian linear accelerators and software including Halcyon, TrueBeam, and HyperArc.
  • This investment helps to address the cancer burden in rural and regional Australia and underserved communities in Singapore and China," said Mark Middleton, CEO of Icon Group.
  • "As the cancer burden continues to rise, we are proud to work with our global partners at Icon Group to expand access to advanced cancer care to achieve a world without fear of cancer.
  • With an Intelligent Cancer Care approach, we are harnessing advanced technologies like artificial intelligence, machine learning and data analytics to enhance cancer treatment and expand access to care.

PTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600

Retrieved on: 
Thursday, April 15, 2021
Companies, S&P 600, Domtar, S&P 400, Varian Medical Systems, PTC, New York Stock Exchange, Stock exchanges, Stock market

b'NEW YORK, April 15, 2021 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20:\nS&P MidCap 400 constituent PTC Inc. (NASD:PTC) will replace Varian Medical Systems Inc. (NYSE:VAR) in the S&P 500, and Lattice Semiconductor Co. (NASD:LSCC) will replace PTC in the S&P MidCap 400.

Key Points: 
  • b'NEW YORK, April 15, 2021 /PRNewswire/ --S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on Tuesday, April 20:\nS&P MidCap 400 constituent PTC Inc. (NASD:PTC) will replace Varian Medical Systems Inc. (NYSE:VAR) in the S&P 500, and Lattice Semiconductor Co. (NASD:LSCC) will replace PTC in the S&P MidCap 400.
  • Siemens Healthineers AG (XETR: SHL) acquired Varian Medical Systems Inc. in a deal that closed today, April 15.\nProgyny Inc. (NASD:PGNY) will replace Domtar Corp. (NYSE:UFS) in the S&P MidCap 400, and Domtar will replace NIC Inc. (NASD:EGOV) in the S&P SmallCap 600.
  • S&P 500 constituent Tyler Technologies Inc. (NYSE:TYL) is acquiring NIC in a deal expected to close soon pending final conditions.
  • Domtar has a market capitalization more representative of the small-cap market space.\nFollowing is a summary of the changes that will take place prior to the open of trading on the effective date:\n'